These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 513240)

  • 1. At year's end, what's new with interferon?
    Check WA
    JAMA; 1979 Dec; 242(26):2829-30. PubMed ID: 513240
    [No Abstract]   [Full Text] [Related]  

  • 2. The natural killer cell-interferon system in human carcinoma--its relation to interferon cancer treatment trials.
    Ching NP; Ching CY; Jim EL; Loh KK; Oishi N; Yim DW
    Hawaii Med J; 1984 Oct; 43(10):368-72. PubMed ID: 6210268
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon--the prospects and problems of its use in therapeutic and oncological practice].
    Poverennyĭ AM
    Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon: a perspective.
    Weissman RM; Droller MJ
    Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of mouse NK cells by interferon.
    Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H
    Transplant Proc; 1979 Mar; 11(1):993-6. PubMed ID: 452109
    [No Abstract]   [Full Text] [Related]  

  • 6. [Natural killer cells in the interferon therapy of cancer patients].
    Shparyk IaV; Bilynskiĭ BT; Shloma DV
    Vopr Onkol; 1991; 37(2):136-43. PubMed ID: 1707569
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
    Lee SH; Kelley S; Chiu H; Stebbing N
    Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells.
    Herberman RB
    Prog Clin Biol Res; 1989; 288():161-7. PubMed ID: 2470107
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon treatment of human neoplasia.
    Strander H
    Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferons: several questions and few answers.
    Stewart WE
    Adv Exp Med Biol; 1983; 166():15-21. PubMed ID: 6196954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells and naturally occurring antibodies as representatives of natural tumor immunity.
    Ehrlich R; Witz IP
    Pathobiol Annu; 1982; 12():85-113. PubMed ID: 6186979
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon therapy and natural killer activity in intracranial tumor-bearing mice].
    Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
    Nihon Geka Hokan; 1983 Jan; 52(1):67-71. PubMed ID: 6194767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-viral and anti-neoplastic actions of interferon--with special reference to its clinical application].
    Imanishi J
    Nihon Rinsho; 1980 Sep; 38(9):3272-81. PubMed ID: 6166771
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon].
    de Maeyer E
    Nouv Presse Med; 1979 Sep; 8(36):2871-2. PubMed ID: 493090
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of biological activity of interferons.
    Battistini A; Affabris E; Fiorucci G; Coccia EM; Romeo G; Marziali G; Rossi GB
    Ann Ist Super Sanita; 1990; 26(3-4):227-53. PubMed ID: 1708952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferons: rationale for clinical trials in neoplastic disease.
    Borden EC
    Ann Intern Med; 1979 Sep; 91(3):472-9. PubMed ID: 382941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor activity of human interferons: their direct cytotoxic activity and clinical effects].
    Shimoyama M; Yamada H; Kitahara T; Adachi I; Yoshida S; Okazaki N; Tobinai K; Konda C; Kakizoe T; Matsumoto K; Ise T; Ichikawa H
    Gan No Rinsho; 1983 May; 29(6):589-97. PubMed ID: 6192265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and natural killer cells in murine Chagas' disease.
    Quan PC; Rager-Zisman B; Wittner M; Tanowitz HB
    J Parasitol; 1983 Dec; 69(6):1164-6. PubMed ID: 6201603
    [No Abstract]   [Full Text] [Related]  

  • 20. Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons.
    Herberman RB; Thurman GB
    J Biol Response Mod; 1983; 2(6):548-62. PubMed ID: 6198476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.